These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11704744)

  • 21. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
    Clark NM; Grim SA; Lynch JP
    Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
    Wiley JM; Seibel NL; Walsh TJ
    Pediatr Infect Dis J; 2005 Feb; 24(2):167-74. PubMed ID: 15702047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation and management of fungal infections in immunocompromised patients.
    Venkatesan P; Perfect JR; Myers SA
    Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antifungal medication: new substances, new experiences].
    Buchheidt D; Hofmann WK
    Dtsch Med Wochenschr; 2016 Nov; 141(24):1752-1756. PubMed ID: 27903025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fungal infection in cardiothoracic transplant recipients: outcome without systemic amphotericin therapy.
    Dhar D; Dickson JL; Carby MR; Lyster HS; Hall AV; Banner NR
    Transpl Int; 2012 Jul; 25(7):758-64. PubMed ID: 22624721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungal infection in solid organ recipients.
    Fortún J; Ruiz I; Martín-Dávila P; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():49-56. PubMed ID: 22542035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
    Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
    Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mold Infections in Solid Organ Transplant Recipients.
    Lemonovich TL
    Infect Dis Clin North Am; 2018 Sep; 32(3):687-701. PubMed ID: 30146030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
    Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
    Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of drug and food interactions with azole antifungal agents in transplant recipients.
    Dodds-Ashley E
    Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
    Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
    J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive mycoses: strategies for effective management.
    Kontoyiannis DP
    Am J Med; 2012 Jan; 125(1 Suppl):S25-38. PubMed ID: 22196206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?
    Muñoz P; Singh N; Bouza E
    Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fungal infections in solid organ transplantation: An update on diagnosis and treatment.
    Kabir V; Maertens J; Kuypers D
    Transplant Rev (Orlando); 2019 Apr; 33(2):77-86. PubMed ID: 30579665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.
    Anesi JA; Baddley JW
    Infect Dis Clin North Am; 2016 Mar; 30(1):277-96. PubMed ID: 26739603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empiric antifungal therapy in patients with febrile neutropenia.
    Ferrara JJ; MacDougall C; Gallagher JC
    Pharmacotherapy; 2011 Apr; 31(4):369-85. PubMed ID: 21449626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
    Michallet M; Ito JI
    J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive fungal infections in the intensive care unit.
    Vazquez JA
    Semin Respir Crit Care Med; 2010 Feb; 31(1):79-86. PubMed ID: 20101550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.